Clinical Trial Search

Primary: Primary Efficacy Endpoint: The Number of Patients in Each Treatment Group With a Therapeutic Cure of Tinea Pedis (Equivalence: Per-Protocol Population) — 89; 90…

Primary: Change From Baseline in the YMRS Total Score at Week 16 — -15.2 Units on a scale

Primary: Change From Baseline at 60 Hours in 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score — -12.12; -14.62 score on a scale — p=0.0160

Primary: Percentages of Participants Showing Clinical Benefit by Renal Function Stratification — 4.76; 3.77; 14.29; 16.04 Percentages of partcipants — p=0.9423

Primary: Change in Lipid Panel From Baseline at 6, 12 and 18 Months. — 160; 170; 163; 172 mg/dL

Primary: Progression Free Survival (PFS) — 4 months

Primary: Change in Body Weight (kg) From Pre- to Post-holiday and 14-week Follow-up Post-holiday — 2.65; -0.13; 1.51; -0.15 kg

Primary: Change From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score — -14.04; -19.54; -17.72 score on a scale — p=0.0013

Primary: Mean Systolic Blood Pressure — 151.59; 152.64; 155.42; 151.74 mmHg

Primary: Percentage of Participants With Complete Response (CR) at End of Induction (EOI), as Determined by the Independent Review Committee (IRC) Using Modified Lugano 2014…

Primary: Mean Bucco-Lingual Change at 3mm — -0.84; -1.01 mm

Primary: Percentage of Participants With Erythroid Hematological Improvement (HI-E) Starting Before the Completion of Five Cycles of Treatment (Responder Rate) — 0; 66.7; 42.9…

Primary: Kilocalories Consumed — 412; 553 Kilocalorie

Primary: Number of Participants With Local Recurrence in the Spared NPC Niches — 0 Participants

Primary: Change From Baseline in Glycated Hemoglobin (HbA1c) to Week 26: Core Period — -1.02; -0.38 percentage of HbA1c — p=<0.0001